Cardiobionic India Profile
Key Indicators
- Authorised Capital ₹ 21.00 Cr
- Paid Up Capital ₹ 20.59 Cr
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 5936.90%
- Profit Growth -423.34%
- Ebitda -452.28%
- Net Worth 105.09%
- Total Assets 105.08%
About Cardiobionic India
Cardiobionic India Private Limited (CIPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 March 2021 (Three years and ten months 17 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 21.00 Cr and a paid-up capital of Rs 20.59 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Cardiobionic India Private Limited India is Kalpana Sharma as COMPANY SECRETARY. Purrshottam Bhaggeria, Madhav Bhageria, and Rajagopalan Prashanth serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33125DL2021PTC378674
-
Company No.
378674
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Mar 2021
-
Date of AGM
27 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Cardiobionic India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kalpana Sharma | Company Secretary | 21-Oct-2024 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Purrshottam Bhaggeria
|
Director | 16-Mar-2021 | Current |
|
Madhav Bhageria
|
Director | 16-Mar-2021 | Current |
|
Rajagopalan Prashanth
|
Director | 16-Mar-2021 | Current |
Financial Performance of Cardiobionic India.
Cardiobionic India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 5936.9% increase. The company also saw a substantial fall in profitability, with a 423.34% decrease in profit. The company's net worth Soared by an impressive increase of 105.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cardiobionic India?
In 2023, Cardiobionic India had a promoter holding of 70.31% and a public holding of 29.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Tapti Valley Education FoundationMadhav Bhageria is a mutual person
-
Phd Chamber Of Commerce And IndustryPurrshottam Bhaggeria is a mutual person
-
Filatex India LimitedPurrshottam Bhaggeria and Madhav Bhageria are mutual person
-
Mgm Healthcare Private LimitedRajagopalan Prashanth is a mutual person
-
Azimuth Investments LimitedPurrshottam Bhaggeria is a mutual person
-
Grand Estates LlpPurrshottam Bhaggeria is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cardiobionic India?
Cardiobionic India has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cardiobionic India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cardiobionic India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
